查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492518

头孢拉嗪市场：按配方、应用和分销管道划分 - 2024-2030 年全球预测

Cephradine Market by Formulation (Capsules, Injectable, Oral Suspension), Application (Respiratory Tract Infections, Skin & Structure Infections, Urinary Tract Infections), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年头孢拉嗪市场规模为44,157万美元，预计2024年将达45,376万美元，2030年将达5,4013万美元，复合年增长率为2.91%。

头孢拉嗪是一种属于头孢菌素家族的抗生素，可透过抑制细菌形成细胞壁的能力来杀死细菌，用于治疗细菌感染。头孢拉嗪的使用增加是因为它能有效治疗多种细菌感染疾病，包括皮肤感染疾病、尿道感染和呼吸道感染疾病。此外，与更有效的抗生素相比，它们相对较高的患者耐受性也有助于它们在临床使用中的普及。然而，对头孢菌素类抗生素过敏的患者可能会出现过敏反应，并且过度使用导致抗生素抗药性细菌的产生，这是一个严重且严重的公共卫生问题。然而，减少常见副作用或提高药物疗效的配方改进如果能提高接受度和利用率，则可能会增加采用率。对可减轻抗药性并提高疗效的联合治疗的研究也可能提供新的市场机会。

主要市场统计
基准年[2023] 44157万美元
预测年份 [2024] 45376万美元
预测年份 [2030] 54013万美元
复合年增长率（%） 2.91%

区域洞察

在美国，主要是美国，头孢拉嗪市场受到严格的监管标准和确保临床环境中可靠分销和使用的成熟医疗基础设施的影响。人们非常关注对抗抗生素抗药性，这也影响了头孢拉嗪等抗生素的处方方式。由于不同的经济、医疗保健和法规环境，欧洲、中东和非洲的市场动态差异很大。由于强大的医疗保健系统和积极的政府医疗保健政策，欧洲国家通常对新的有效治疗方法的采用率很高。然而，在中东和非洲地区，虽然医疗意识有所提高，医疗实践也有所改善，但由于医疗体係不够发达，就医机会参差不齐，市场成长受到限制。由于医疗成本上升和健康问题意识增强，亚太地区的情况正在恶化。中国和印度等人口众多、医疗基础建设完善的国家为头孢拉嗪的扩张提供了巨大的机会。

FPNV定位矩阵

FPNV定位矩阵对于评估供应商在头孢拉定的定位至关重要。此矩阵提供了对供应商的全面评估，并检查了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对头孢拉定供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对头孢拉定当前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地细菌感染疾病的盛行率增加
      • 治疗细菌感染疾病的个人化医疗趋势日益明显
    • 抑制因素
      • 对头孢拉嗪潜在不良反应和副作用的担忧
    • 机会
      • 创新药物传递机制以提高功效和便利性
      • 持续投资研发以发现新配方
    • 任务
      • 各地区严格的监管标准和合规要求
  • 市场区隔分析
    • 配方：注射头孢拉嗪在临床环境中快速反应的适用性
    • 用途：由于细菌酵素的抗性而有效治疗呼吸道感染疾病
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章头孢拉嗪市场：依配方分类

  • 胶囊
  • 可注射的
  • 口服混悬剂

第七章头孢拉嗪市场：依应用分类

  • 呼吸道感染疾病
  • 皮肤和结构感染疾病
  • 尿道感染

第八章头孢拉嗪市场：依分销管道划分

  • 医院药房
  • 网路药房
  • 零售药房

第9章头孢拉嗪在美洲

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章 头孢拉嗪在亚太地区

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的头孢拉嗪

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 市场占有率分析（2023）
  • FPNV定位矩阵（2023）
  • 竞争情境分析
    • 解决抗菌素抗药性： FDA核准新抗生素头孢比普罗
    • FDA 要求提供有关 Venatorx 和 Melinta 抗生素 NDA 的更多资料
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46BFF9

[184 Pages Report] The Cephradine Market size was estimated at USD 441.57 million in 2023 and expected to reach USD 453.76 million in 2024, at a CAGR 2.91% to reach USD 540.13 million by 2030.

Cephradine is a type of antibiotic that belongs to the cephalosporin class, used in bacterial infections treatment by impeding the bacteria's ability to form cell walls, which results in bacterial death. The factors contributing to the increased use of Cephradine include its effectiveness in treating a range of bacterial infections including skin infections, urinary tract infections, and respiratory tract infections. Additionally, its relatively well-tolerated nature by patients compared to more potent antibiotics contributes to its popularity in clinical use. However, potential allergic reactions in individuals sensitive to cephalosporins and their overuse lead to the development of antibiotic-resistant bacteria, a significant and growing public health issue. Nevertheless, formulation enhancements that reduce common side effects or improve the efficacy of the drug, thereby boosting its acceptability and usage, may increase its adoption. Research into combination therapies that could potentially mitigate resistance and increase effectiveness might also present new market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 441.57 million
Estimated Year [2024] USD 453.76 million
Forecast Year [2030] USD 540.13 million
CAGR (%) 2.91%

Regional Insights

In the Americas, particularly the United States, the Cephradine market is influenced by stringent regulatory standards and a well-established healthcare infrastructure that ensures its reliable distribution and usage in clinical settings. There is a significant focus on combating antibiotic resistance, which affects how antibiotics such as cephradine are prescribed. In the EMEA region, market dynamics vary widely due to the diverse economic, healthcare, and regulatory environments. European countries often see a high adoption rate of new and effective treatments due to strong healthcare systems and active governmental healthcare policies. However, in the Middle East and Africa, the market growth is constrained by less-developed healthcare systems and varying degrees of access to medical treatments, although there is growing awareness and some improvement in healthcare practices. The Asia Pacific region showcases a growing landscape for cephradine, driven by increasing healthcare expenditures and growing awareness of health issues. Countries including China and India, with their large populations and improving healthcare infrastructure, offer significant opportunities for the expansion of the Cephradine market.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Cephradine Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of bacterial infections worldwide
      • Rising trend toward personalized medicine for the treatment of bacterial infections
    • Market Restraints
      • Concerns over potential adverse effects or side effects of cephradine
    • Market Opportunities
      • Innovations in drug delivery mechanisms to enhance the efficacy and convenience
      • Continued investments in research and development to discover new formulations
    • Market Challenges
      • Strict regulatory standards and compliance requirements across different regions
  • Market Segmentation Analysis
    • Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
    • Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cephradine Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cephradine Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole

In response to the escalating threat of antimicrobial resistance (AMR), the FDA recently approved a novel antibiotic, Zevtera (ceftobiprole medocaril sodium for injection), which enhances the arsenal against stubborn infections. Zevtera is sanctioned for treating adults with Staphylococcus aureus bloodstream infections, including right-sided infective endocarditis, severe bacterial skin infections, and bacterial pneumonia in both adults and older infants. [Published On: 2024-04-04]

FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA

Venatorx Pharmaceuticals and Melinta Therapeutics have received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) concerning their New Drug Application for cefepime-taniborbactam, designed to treat complicated urinary tract infections in adults, including acute pyelonephritis. Both companies expressed their commitment to fulfilling the FDA's requests swiftly. [Published On: 2023-02-23]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cephradine Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cephradine Market, highlighting leading vendors and their innovative profiles. These include Bristol-Myers Squibb Company, Corden Pharma GmbH, E.R. Squibb & Sons, L.L.C., Fengchen Group Co.,Ltd, GlaxoSmithKline PLC, Hanmi Pharm.Co.,Ltd., Livzon Pharmaceutical Group Co., Lupin Limited, Qilu Pharmaceutical Co., Ltd., Sandoz Group AG, SimSon Pharma Limited, Taj Pharmaceuticals Limited, and Teva Pharmaceuticals.

Market Segmentation & Coverage

This research report categorizes the Cephradine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Formulation
    • Capsules
    • Injectable
    • Oral Suspension
  • Application
    • Respiratory Tract Infections
    • Skin & Structure Infections
    • Urinary Tract Infections
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of bacterial infections worldwide
      • 5.1.1.2. Rising trend toward personalized medicine for the treatment of bacterial infections
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns over potential adverse effects or side effects of cephradine
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovations in drug delivery mechanisms to enhance the efficacy and convenience
      • 5.1.3.2. Continued investments in research and development to discover new formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory standards and compliance requirements across different regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Formulation: Suitability of injectable form of Cephradine in clinical settings for rapid response
    • 5.2.2. Application: Effectiveness of cephradine respiratory tract infections due to its ability to withstand bacterial enzymes
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Cephradine Market, by Formulation

  • 6.1. Introduction
  • 6.2. Capsules
  • 6.3. Injectable
  • 6.4. Oral Suspension

7. Cephradine Market, by Application

  • 7.1. Introduction
  • 7.2. Respiratory Tract Infections
  • 7.3. Skin & Structure Infections
  • 7.4. Urinary Tract Infections

8. Cephradine Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Cephradine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cephradine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cephradine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Addressing Antimicrobial Resistance: FDA Approves New Antibiotic Ceftobiprole
    • 12.3.2. FDA Requests Additional Data for Venatorx and Melinta's Antibiotic NDA
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CEPHRADINE MARKET RESEARCH PROCESS
  • FIGURE 2. CEPHRADINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CEPHRADINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CEPHRADINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CEPHRADINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CEPHRADINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CEPHRADINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CEPHRADINE MARKET SIZE, BY CAPSULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CEPHRADINE MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CEPHRADINE MARKET SIZE, BY ORAL SUSPENSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CEPHRADINE MARKET SIZE, BY RESPIRATORY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CEPHRADINE MARKET SIZE, BY SKIN & STRUCTURE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CEPHRADINE MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CEPHRADINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CEPHRADINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CEPHRADINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES CEPHRADINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CEPHRADINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY FORMULATION, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM CEPHRADINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 285. CEPHRADINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. CEPHRADINE MARKET, FPNV POSITIONING MATRIX, 2023